Jean Campbell's Pain Control Advocacy in ELLE UK March 2025 Lensed by Ekua King AOC Body

Scottish-born beauty and top model Jean Campbell previews lingerie-inspired lace and leather mixes, accessorized with big gold jewelry in true 1980s spirit, lensed by Ekua King [IG] for the March 2025 issue of British ELLE.

Streamlined, dance-inspired fashion from Christian Dior on the digital cover, gets an editorial boost from Acne Studios, Chanel, Chloé, Dolce & Gabbana, Fendi, Hermes, Khaite, Prada, Saint Laurent by Anthony Vaccarello and more, styled by Jenny Kennedy. See all the product credits and prices at ELLE UK. / Hair by hiroshi Matsushita; makeup by Pamela Cochrane

Clementina Jackson chats with Lady Campbell, revisiting the topic of pain in her life and the podcast ‘I’m Fine’ she created to talk about it.

In her podcast, Jean Campbell talks to people about their own experiences with pain management, while sharing information about new research and test results in the field. Following her lead, AOC takes a look at the latest breakthroughs in learning to embrace chronic pain while not letting it define us.

The Patient Assumes New Powers in Pain Management

Emerging pain management techniques are transforming the landscape of healthcare, providing patients with innovative solutions that go beyond traditional methods such as opioids or surgery. As our understanding of pain physiology advances, so too does our capacity to address it more effectively and safely, led by patient-driven initiatives.

One key trend is the integration of technology with medical care, exemplified by the rise of digital health applications and telemedicine platforms. These tools offer real-time monitoring and tailored therapeutic interventions, empowering patients to play a more active role in managing their conditions.

Not only are patients becoming more empowered and engaged in their own pain management, their tools and information necessary for making decisions involves highly-specific information about their own bodies. The one-size-fits-all approach to healthcare has been largely abandoned.

By integrating genetic profiling into treatment plans, healthcare providers can anticipate how patients might respond to different pain medications, thereby enhancing efficacy and minimizing adverse effects.

Personalized medicine moves beyond this one-dimensional approach to pain management and addresses the multifaceted nature of pain more comprehensively. By analyzing an individual’s genetic makeup, healthcare providers can tailor medication choices to optimize effectiveness and minimize adverse reactions.

Non-Opioid Pain Management

In recent years, the focus on non-opioid pain management alternatives has gained significant attention as healthcare providers strive to mitigate the risks associated with opioid use, such as addiction and overdose. This shift has led to the exploration and adoption of various innovative strategies and treatments aimed at effectively managing pain without the reliance on opioid medications. One of the most promising alternatives includes the use of nonsteroidal anti-inflammatory drugs [NSAIDs], which are commonly prescribed to reduce inflammation and relieve pain without the addictive properties of opioids.

On February 4, 2025, CNN’s Dr. Sanjay Gupta spoke about the U.S Food and Drug Administration [FDA] approval of Journavx, or suzetrigine, oral tablets. “These pain medications, suzetrigine, Journavx as it’s called, work . . . more at the location of the pain, . . . trying to block the signals coming from the source of pain, going to the brain. As a result, you shouldn’t get euphoria,” Dr. Gupta explained. And, what is so critical about this breakthrough, is its lack of addictive ingredients.